1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Haemophilia Care in Europe: the ESCHQoL study
Schramm, W. ; Gringeri, A. ; Ljung, Rolf LU
; Berger, K.
; Crispin, A.
; Bullinger, M.
; Giangrande, P. L. F.
; Von Mackensen, S.
; Mantovani, L. G.
and Nemes, L.
, et al.
(2012)
In Haemophilia
18(5).
p.729-737
- Contribution to journal › Article
- 2011
-
Mark
The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data
(2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.31-31
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
Hoots, W. K. ; Ebbesen, L. S. ; Konkle, B. A. ; Auerswald, G. K. -H. ; Roberts, H. R. ; Weatherall, J. ; Ferran, J. -M. ; Ljung, Rolf LU
; Bianco, R. Perez
and Ozelo, M. Castro
, et al.
(2008)
In Haemophilia
14(3).
p.466-466
- Contribution to journal › Article